TMDA Tanzania: Warns of Fake TEMEVAC NDV Vaccine

• The Tanzania Medicines and Medical Devices Authority (TMDA) has issued a warning about counterfeit TEMEVAC NDV STRAIN 1-2 vaccine.
• This fake livestock vaccine has been found circulating in the Tanzanian market.
• The TMDA considers the counterfeit TEMEVAC NDV STRAIN 1-2 an illicit veterinary drug.
• The presence of this fraudulent product poses significant risks to animal health and agricultural productivity in Tanzania.
• Stakeholders are urged to ensure compliance with TMDA directives and maintain supply chain integrity to combat the TEMEVAC NDV STRAIN 1-2 fraud.

The TMDA's directive underscores a significant breach in pharmaceutical compliance and supply chain integrity, prompting immediate concern across the agricultural sector.

The Tanzania Medicines and Medical Devices Authority (TMDA) has issued a critical public alert regarding the circulation of a counterfeit livestock vaccine within the Tanzanian market. This warning specifically identifies a fraudulent version of "TEMEVAC NDV STRAIN 1-2," a product essential for animal health. The TMDA's directive underscores a significant breach in pharmaceutical compliance and supply chain integrity, prompting immediate concern across the agricultural sector.

The illicit veterinary drug, identified as a fake TEMEVAC NDV STRAIN 1-2, poses substantial risks to livestock and the broader farming community. Its unauthorized presence signifies a deliberate attempt to defraud consumers and potentially endanger animal welfare through ineffective or harmful substances. This alert from the TMDA highlights the ongoing challenges faced by regulatory bodies in combating the proliferation of unapproved and substandard veterinary products.

Under Tanzanian law, the TMDA is mandated to regulate the quality, safety, and efficacy of all medicines and medical devices, including veterinary products. The discovery of counterfeit TEMEVAC NDV STRAIN 1-2 represents a direct challenge to this regulatory oversight. The Authority's warning serves as a reminder to all stakeholders, from manufacturers and distributors to veterinary practitioners and farmers, of their legal obligations to source and utilize only approved and genuine products.

The distribution and use of illicit veterinary drugs, such as the fake TEMEVAC NDV STRAIN 1-2, carry severe legal penalties. Entities found to be involved in the TEMEVAC NDV STRAIN 1-2 fraud could face prosecution, fines, and revocation of licenses, reflecting the government's commitment to upholding public and animal health standards. This incident underscores the critical importance of robust supply chain integrity and adherence to Tanzania pharmaceutical compliance standards to prevent such fraudulent products from reaching the market.

The proliferation of counterfeit TEMEVAC NDV STRAIN 1-2 vaccine in Tanzania has far-reaching implications beyond immediate animal health concerns. Ineffective vaccination due to the use of fake products can lead to widespread disease outbreaks, severely impacting livestock populations and, consequently, the livelihoods of countless farmers. This situation creates a significant economic burden, as farmers incur losses from animal mortality, reduced productivity, and wasted investment in fraudulent treatments.

Furthermore, the presence of illicit veterinary drugs like the fake TEMEVAC NDV STRAIN 1-2 erodes trust in the legitimate pharmaceutical supply chain and regulatory bodies. It can deter farmers from seeking proper veterinary care, leading to a decline in overall animal health standards and potentially affecting food security. The TMDA's proactive stance with this Tanzania livestock vaccine alert is crucial for safeguarding the integrity of the agricultural sector and ensuring the long-term sustainability of animal farming practices in the nation.

Lawyers and compliance officers advising clients in the Tanzanian veterinary or agricultural sectors should immediately alert them to the presence of counterfeit TEMEVAC NDV STRAIN 1-2 vaccine. They must review supply chain integrity and ensure compliance with TMDA directives to avoid legal liabilities associated with the distribution or use of illicit veterinary products.

Source: Original reporting via TMDA public alert